Glecaprevir/pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Glecaprevir/pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

Poordad F, Pol S, Asatryan A, et al. Glecaprevir/pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure. Hepatology. 2018;67(4):1260.

Publication Type:

Journal Article

Authors:

Poordad, F; Pol, S; Asatryan, A; et, al

Source:

Hepatology, Volume 67, Issue 4, p.1260 (2018)

Cited On:

Sofosbuvir-Based and Elbasvir/Grazoprevir Treatment Failures

Export Citation:

RIS Format

Top